STANDEX ACQUIRES CUSTOM BIOGENIC SYSTEMS
Standex International (NYSE:SXI) has acquired Michigan-based Custom Biogenic Systems (CBS) for $6.2 million in cash, financed from existing cash balance.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Standex International (NYSE:SXI) has acquired Michigan-based Custom Biogenic Systems (CBS) for $6.2 million in cash, financed from existing cash balance. CBS, a leader in cryogenic equipment manufacturing with estimated $15 million in revenues for 2024, will be integrated into Standex's Scientific business segment. The acquisition expands Standex's scientific refrigeration business into liquid nitrogen and controlled rate freezer markets. CBS specializes in developing advanced cryogenic equipment with dry liquid nitrogen technology for pharmaceutical and biobank markets. The acquisition is expected to be earnings accretive in the first year.
Positive
- All-cash acquisition of $6.2 million funded from existing cash balance
- Expected to be earnings accretive in first year
- Target company has estimated revenues of $15 million in 2024
- Expands addressable market in scientific refrigeration segment
- Adds new capabilities in liquid nitrogen and controlled rate freezer markets
Negative
- None.
Details
News Market Reaction – SXI
The recorded move for SXI in the trading session of this news was +0.03%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
"We are pleased to have acquired Custom Biogenic Systems, extending the reach of our scientific refrigeration business with a presence within the liquid nitrogen and controlled rate freezer markets and expanding our North American manufacturing capabilities. The business aligns with our customer intimacy approach and is highly complementary to our existing business," commented President and Chief Executive Officer David Dunbar.
Founded in 1987, Custom Biogenic Systems is a leader in the design and manufacturing of laboratory products and supplies. CBS specializes in the development and manufacturing of advanced cryogenic equipment, including unique Isothermal freezers with dry liquid nitrogen technology, to the pharmaceutical and biobank end markets within life sciences. In calendar year 2024, Custom Biogenic Systems estimates revenues of approximately
"With today's announcement, we have expanded our addressable market within our Scientific business with the addition of a brand leader in cryogenic storage, with over thirty years of industry experience. Considering its adjacent scientific product offering, complementary nature to our existing products, and its engineering and manufacturing capabilities, we are excited about our long-term combined potential together. We look forward to welcoming the entire CBS team to our company," concluded Dunbar.
About Standex
Standex International Corporation is a global multi-industry manufacturer in five broad business segments: Electronics, Engraving, Scientific, Engineering Technologies, and Specialty Solutions with operations in
About Custom Biogenic Systems
Headquartered in
View original content to download multimedia:https://www.prnewswire.com/news-releases/standex-acquires-custom-biogenic-systems-302306288.html
SOURCE Standex International Corporation
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.